Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Genome-wide scan identifies novel genetic loci regulating salivary metabolite levels.

Nag A, Kurushima Y, Bowyer RCE, Wells PM, Weiss S, Pietzner M, Kocher T, Raffler J, Völker U, Mangino M, Spector TD, Milburn MV, Kastenmüller G, Mohney RP, Suhre K, Menni C, Steves CJ.

Hum Mol Genet. 2020 Jan 21. pii: ddz308. doi: 10.1093/hmg/ddz308. [Epub ahead of print]

PMID:
31960908
2.

Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience.

Gorsi HS, Malicki DM, Barsan V, Tumblin M, Yeh-Nayre L, Milburn M, Elster JD, Crawford JR.

J Pediatr Hematol Oncol. 2019 May;41(4):e235-e241. doi: 10.1097/MPH.0000000000001339.

PMID:
30681550
3.

Single-agent bevacizumab in the treatment of recurrent or refractory pediatric low-grade glioma: A single institutional experience.

Gorsi HS, Khanna PC, Tumblin M, Yeh-Nayre L, Milburn M, Elster JD, Crawford JR.

Pediatr Blood Cancer. 2018 Sep;65(9):e27234. doi: 10.1002/pbc.27234. Epub 2018 May 11.

PMID:
29750399
4.

The Carnism Inventory: Measuring the ideology of eating animals.

Monteiro CA, Pfeiler TM, Patterson MD, Milburn MA.

Appetite. 2017 Jun 1;113:51-62. doi: 10.1016/j.appet.2017.02.011. Epub 2017 Feb 9.

PMID:
28189749
5.

Hypoxia-mediated impaired erythrocyte Lands' Cycle is pathogenic for sickle cell disease.

Wu H, Bogdanov M, Zhang Y, Sun K, Zhao S, Song A, Luo R, Parchim NF, Liu H, Huang A, Adebiyi MG, Jin J, Alexander DC, Milburn MV, Idowu M, Juneja HS, Kellems RE, Dowhan W, Xia Y.

Sci Rep. 2016 Jul 20;6:29637. doi: 10.1038/srep29637.

6.

Erratum to: Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism.

Miller MJ, Kennedy AD, Eckhart AD, Burrage LC, Wulff JE, Miller LAD, Milburn MV, Ryals JA, Beaudet AL, Sun Q, Sutton VR, Elsea SH.

J Inherit Metab Dis. 2016 Sep;39(5):757. doi: 10.1007/s10545-016-9944-y. No abstract available.

7.

Plasma metabolomic profiles enhance precision medicine for volunteers of normal health.

Guo L, Milburn MV, Ryals JA, Lonergan SC, Mitchell MW, Wulff JE, Alexander DC, Evans AM, Bridgewater B, Miller L, Gonzalez-Garay ML, Caskey CT.

Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4901-10. doi: 10.1073/pnas.1508425112. Epub 2015 Aug 17.

8.

Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism.

Miller MJ, Kennedy AD, Eckhart AD, Burrage LC, Wulff JE, Miller LA, Milburn MV, Ryals JA, Beaudet AL, Sun Q, Sutton VR, Elsea SH.

J Inherit Metab Dis. 2015 Nov;38(6):1029-39. doi: 10.1007/s10545-015-9843-7. Epub 2015 Apr 15. Erratum in: J Inherit Metab Dis. 2016 Sep;39(5):757.

9.

Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.

Aristizabal P, Singer J, Cooper R, Wells KJ, Nodora J, Milburn M, Gahagan S, Schiff DE, Martinez ME.

Pediatr Blood Cancer. 2015 Aug;62(8):1337-44. doi: 10.1002/pbc.25472. Epub 2015 Mar 8.

10.

Bladder cancer biomarker discovery using global metabolomic profiling of urine.

Wittmann BM, Stirdivant SM, Mitchell MW, Wulff JE, McDunn JE, Li Z, Dennis-Barrie A, Neri BP, Milburn MV, Lotan Y, Wolfert RL.

PLoS One. 2014 Dec 26;9(12):e115870. doi: 10.1371/journal.pone.0115870. eCollection 2014.

11.

A rare case of an Essex-Lopresti injury secondary to a gunshot wound.

Erickson BJ, Fillingham YA, Cvetanovich GL, Szatkowski JP, Milburn MW.

Pol Orthop Traumatol. 2014 Jul 7;79:97-101.

PMID:
25001924
12.

Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics.

Lawton KA, Brown MV, Alexander D, Li Z, Wulff JE, Lawson R, Jaffa M, Milburn MV, Ryals JA, Bowser R, Cudkowicz ME, Berry JD; Northeast ALS Consortium.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):362-70. doi: 10.3109/21678421.2014.908311. Epub 2014 Jul 1.

PMID:
24984169
13.

Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression.

Zhang Y, Berka V, Song A, Sun K, Wang W, Zhang W, Ning C, Li C, Zhang Q, Bogdanov M, Alexander DC, Milburn MV, Ahmed MH, Lin H, Idowu M, Zhang J, Kato GJ, Abdulmalik OY, Zhang W, Dowhan W, Kellems RE, Zhang P, Jin J, Safo M, Tsai AL, Juneja HS, Xia Y.

J Clin Invest. 2014 Jun;124(6):2750-61. doi: 10.1172/JCI74604. Epub 2014 May 16.

14.

An atlas of genetic influences on human blood metabolites.

Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, Arnold M, Erte I, Forgetta V, Yang TP, Walter K, Menni C, Chen L, Vasquez L, Valdes AM, Hyde CL, Wang V, Ziemek D, Roberts P, Xi L, Grundberg E; Multiple Tissue Human Expression Resource (MuTHER) Consortium, Waldenberger M, Richards JB, Mohney RP, Milburn MV, John SL, Trimmer J, Theis FJ, Overington JP, Suhre K, Brosnan MJ, Gieger C, Kastenmüller G, Spector TD, Soranzo N.

Nat Genet. 2014 Jun;46(6):543-550. doi: 10.1038/ng.2982. Epub 2014 May 11.

15.

Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome.

Beebe K, Sampey B, Watkins SM, Milburn M, Eckhart AD.

Clin Transl Sci. 2014 Feb;7(1):74-81. doi: 10.1111/cts.12131. Epub 2014 Jan 14. Review.

16.

Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.

Hartman LL, Crawford JR, Makale MT, Milburn M, Joshi S, Salazar AM, Hasenauer B, VandenBerg SR, MacDonald TJ, Durden DL.

J Pediatr Hematol Oncol. 2014 Aug;36(6):451-7. doi: 10.1097/MPH.0000000000000047.

17.

Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.

Menni C, Fauman E, Erte I, Perry JR, Kastenmüller G, Shin SY, Petersen AK, Hyde C, Psatha M, Ward KJ, Yuan W, Milburn M, Palmer CN, Frayling TM, Trimmer J, Bell JT, Gieger C, Mohney RP, Brosnan MJ, Suhre K, Soranzo N, Spector TD.

Diabetes. 2013 Dec;62(12):4270-6. doi: 10.2337/db13-0570. Epub 2013 Jul 24.

18.

Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis.

Joseloff E, Sha W, Bell SC, Wetmore DR, Lawton KA, Milburn MV, Ryals JA, Guo L, Muhlebach MS.

Pediatr Pulmonol. 2014 May;49(5):463-72. doi: 10.1002/ppul.22859. Epub 2013 Jul 12.

PMID:
23847148
19.

Metabolomic signatures of aggressive prostate cancer.

McDunn JE, Li Z, Adam KP, Neri BP, Wolfert RL, Milburn MV, Lotan Y, Wheeler TM.

Prostate. 2013 Oct;73(14):1547-60. doi: 10.1002/pros.22704. Epub 2013 Jul 3.

20.

Is oncotype DX recurrence score (RS) of prognostic value once HER2-positive and. low-ER expression patients are removed?

Milburn M, Rosman M, Mylander C, Tafra L.

Breast J. 2013 Jul-Aug;19(4):357-64. doi: 10.1111/tbj.12126. Epub 2013 May 23.

PMID:
23701403
21.

Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression.

Brown MV, Compton SA, Milburn MV, Lawton KA, Cheatham B.

Obesity (Silver Spring). 2013 Dec;21(12):E561-70. doi: 10.1002/oby.20440. Epub 2013 Jun 13.

22.

A novel fasting blood test for insulin resistance and prediabetes.

Cobb J, Gall W, Adam KP, Nakhle P, Button E, Hathorn J, Lawton K, Milburn M, Perichon R, Mitchell M, Natali A, Ferrannini E.

J Diabetes Sci Technol. 2013 Jan 1;7(1):100-10.

23.

Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats.

Yamazaki M, Miyake M, Sato H, Masutomi N, Tsutsui N, Adam KP, Alexander DC, Lawton KA, Milburn MV, Ryals JA, Wulff JE, Guo L.

Toxicol Appl Pharmacol. 2013 Apr 1;268(1):79-89. doi: 10.1016/j.taap.2013.01.018. Epub 2013 Jan 27.

PMID:
23360887
24.

Application of metabolomics to diagnosis of insulin resistance.

Milburn MV, Lawton KA.

Annu Rev Med. 2013;64:291-305. doi: 10.1146/annurev-med-061511-134747. Review.

PMID:
23327524
25.

Metabolomic profiles in individuals with negative affectivity and social inhibition: a population-based study of Type D personality.

Altmaier E, Emeny RT, Krumsiek J, Lacruz ME, Lukaschek K, Häfner S, Kastenmüller G, Römisch-Margl W, Prehn C, Mohney RP, Evans AM, Milburn MV, Illig T, Adamski J, Theis F, Suhre K, Ladwig KH.

Psychoneuroendocrinology. 2013 Aug;38(8):1299-309. doi: 10.1016/j.psyneuen.2012.11.014. Epub 2012 Dec 10.

PMID:
23237813
26.

Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance.

Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, Adam KP, Milburn MV, Kastenmüller G, Adamski J, Tuomi T, Lyssenko V, Groop L, Gall WE.

Diabetes. 2013 May;62(5):1730-7. doi: 10.2337/db12-0707. Epub 2012 Nov 16.

27.

Research Highlights: Highlights from the latest articles in metabolomic studies of cancer.

Milburn MV.

Per Med. 2012 Nov;9(8):793-794. doi: 10.2217/pme.12.93. No abstract available.

PMID:
29776227
28.

Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information.

Krumsiek J, Suhre K, Evans AM, Mitchell MW, Mohney RP, Milburn MV, Wägele B, Römisch-Margl W, Illig T, Adamski J, Gieger C, Theis FJ, Kastenmüller G.

PLoS Genet. 2012;8(10):e1003005. doi: 10.1371/journal.pgen.1003005. Epub 2012 Oct 18.

29.

Metabolomics as a key integrator for "omic" advancement of personalized medicine and future therapies.

Eckhart AD, Beebe K, Milburn M.

Clin Transl Sci. 2012 Jun;5(3):285-8. doi: 10.1111/j.1752-8062.2011.00388.x. Review.

30.

Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies.

Brown MV, McDunn JE, Gunst PR, Smith EM, Milburn MV, Troyer DA, Lawton KA.

Genome Med. 2012 Apr 30;4(4):33.

31.

Biochemical alterations associated with ALS.

Lawton KA, Cudkowicz ME, Brown MV, Alexander D, Caffrey R, Wulff JE, Bowser R, Lawson R, Jaffa M, Milburn MV, Ryals JA, Berry JD.

Amyotroph Lateral Scler. 2012 Jan;13(1):110-8. doi: 10.3109/17482968.2011.619197. Epub 2011 Nov 25.

PMID:
22117131
32.

Human metabolic individuality in biomedical and pharmaceutical research.

Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wägele B, Altmaier E; CARDIoGRAM, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, Milburn MV, Prehn C, Raffler J, Ried JS, Römisch-Margl W, Samani NJ, Small KS, Wichmann HE, Zhai G, Illig T, Spector TD, Adamski J, Soranzo N, Gieger C.

Nature. 2011 Aug 31;477(7362):54-60. doi: 10.1038/nature10354.

33.

Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists.

Zgoda-Pols JR, Chowdhury S, Wirth M, Milburn MV, Alexander DC, Alton KB.

Toxicol Appl Pharmacol. 2011 Aug 15;255(1):48-56. doi: 10.1016/j.taap.2011.05.015. Epub 2011 May 27.

PMID:
21640743
34.

Detrimental effects of adenosine signaling in sickle cell disease.

Zhang Y, Dai Y, Wen J, Zhang W, Grenz A, Sun H, Tao L, Lu G, Alexander DC, Milburn MV, Carter-Dawson L, Lewis DE, Zhang W, Eltzschig HK, Kellems RE, Blackburn MR, Juneja HS, Xia Y.

Nat Med. 2011 Jan;17(1):79-86. doi: 10.1038/nm.2280. Epub 2010 Dec 19.

35.

Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.

Suhre K, Meisinger C, Döring A, Altmaier E, Belcredi P, Gieger C, Chang D, Milburn MV, Gall WE, Weinberger KM, Mewes HW, Hrabé de Angelis M, Wichmann HE, Kronenberg F, Adamski J, Illig T.

PLoS One. 2010 Nov 11;5(11):e13953. doi: 10.1371/journal.pone.0013953.

36.

Human acellular dermal matrix for ventral hernia repair reduces morbidity in transplant patients.

Brewer MB, Rada EM, Milburn ML, Goldberg NH, Singh DP, Cooper M, Silverman RP.

Hernia. 2011 Apr;15(2):141-5. doi: 10.1007/s10029-010-0748-y. Epub 2010 Nov 12.

PMID:
21072551
37.

Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.

Wetmore DR, Joseloff E, Pilewski J, Lee DP, Lawton KA, Mitchell MW, Milburn MV, Ryals JA, Guo L.

J Biol Chem. 2010 Oct 1;285(40):30516-22. doi: 10.1074/jbc.M110.140806. Epub 2010 Jul 30.

38.

Ethylene glycol monomethyl ether-induced toxicity is mediated through the inhibition of flavoprotein dehydrogenase enzyme family.

Takei M, Ando Y, Saitoh W, Tanimoto T, Kiyosawa N, Manabe S, Sanbuissho A, Okazaki O, Iwabuchi H, Yamoto T, Adam KP, Weiel JE, Ryals JA, Milburn MV, Guo L.

Toxicol Sci. 2010 Dec;118(2):643-52. doi: 10.1093/toxsci/kfq211. Epub 2010 Jul 8.

39.

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.

Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, Natali A, Ferrannini E; RISC Study Group.

PLoS One. 2010 May 28;5(5):e10883. doi: 10.1371/journal.pone.0010883.

40.

Assessment of the effects of dentifrice on periodontal disease biomarkers in gingival crevicular fluid.

Barnes VM, Teles R, Trivedi HM, Devizio W, Xu T, Lee DP, Mitchell MW, Wulff JE, Milburn MV, Guo L.

J Periodontol. 2010 Sep;81(9):1273-9. doi: 10.1902/jop.2010.100070.

PMID:
20450373
41.

Plasma metabolomic profile in nonalcoholic fatty liver disease.

Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, Milburn M.

Metabolism. 2011 Mar;60(3):404-13. doi: 10.1016/j.metabol.2010.03.006. Epub 2010 Apr 27.

42.

Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline.

Sha W, da Costa KA, Fischer LM, Milburn MV, Lawton KA, Berger A, Jia W, Zeisel SH.

FASEB J. 2010 Aug;24(8):2962-75. doi: 10.1096/fj.09-154054. Epub 2010 Apr 6.

43.

Acceleration of purine degradation by periodontal diseases.

Barnes VM, Teles R, Trivedi HM, Devizio W, Xu T, Mitchell MW, Milburn MV, Guo L.

J Dent Res. 2009 Sep;88(9):851-5. doi: 10.1177/0022034509341967.

PMID:
19767584
44.

Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats.

Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, Milburn MV, Ryals JA, Beebe KD, Guo L.

Toxicol Pathol. 2009 Jun;37(4):521-35. doi: 10.1177/0192623309336152.

PMID:
19458390
45.

Sexual coercion in men and women: similar behaviors, different predictors.

Schatzel-Murphy EA, Harris DA, Knight RA, Milburn MA.

Arch Sex Behav. 2009 Dec;38(6):974-86. doi: 10.1007/s10508-009-9481-y. Epub 2009 Mar 28.

PMID:
19330440
46.

Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent.

Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J, Plotnikov AN, Marimuthu A, Nguyen H, Will S, Signaevsky M, Kral J, Cantwell J, Settachatgull C, Yan DS, Fong D, Oh A, Shi S, Womack P, Powell B, Habets G, West BL, Zhang KY, Milburn MV, Vlasuk GP, Hirth KP, Nolop K, Bollag G, Ibrahim PN, Tobin JF.

Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):262-7. doi: 10.1073/pnas.0811325106. Epub 2008 Dec 30.

47.

Acellular dermal matrix compared with synthetic implant material for repair of ventral hernia in the setting of peri-operative Staphylococcus aureus implant contamination: a rabbit model.

Milburn ML, Holton LH, Chung TL, Li EN, Bochicchio GV, Goldberg NH, Silverman RP.

Surg Infect (Larchmt). 2008 Aug;9(4):433-42. doi: 10.1089/sur.2007.044.

PMID:
18759680
48.

Predictors of home healthcare nurse retention.

Ellenbecker CH, Porell FW, Samia L, Byleckie JJ, Milburn M.

J Nurs Scholarsh. 2008;40(2):151-60. doi: 10.1111/j.1547-5069.2008.00220.x.

PMID:
18507570
49.

Analysis of the adult human plasma metabolome.

Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, Hanson RW, Kalhan SC, Ryals JA, Milburn MV.

Pharmacogenomics. 2008 Apr;9(4):383-97. doi: 10.2217/14622416.9.4.383.

PMID:
18384253
50.

Effect of suture material on tensile strength and complication rate in abdominal fascial defects repaired with acellular dermal matrix.

Winkler AA, Milburn ML, Holton LH 3rd, Goldberg NH, Silverman RP.

Hernia. 2008 Feb;12(1):33-8. Epub 2007 Sep 13. Erratum in: Hernia. 2007 Dec;11(6):555. Holton, L T 3rd [corrected to Holton, L H 3rd].

PMID:
17851729

Supplemental Content

Loading ...
Support Center